Skip to content

ERNAW ERNEXA THERAPEUTICS INC

Follow

*W EXP 02/04/203 (warrant or right), issuer CIK 748592

6 managers (6 13F filers) reported a position in ERNAW shares at 2026-06-30, 2,836,819 shares in all. 1 filer opened a position and 0 filers sold out during the quarter.

Managers
6
13F filers
6
New
1
Added
1
Reduced
2
Sold out
0
Shares held by filers
2,836,819

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Bleichroeder LP2,000,000$143K0.03%013F-HRTimeline
HEIGHTS CAPITAL MANAGEMENT, INCin group HEIGHTS CAPITAL MANAGEMENT, I…400,000$28.5K0.01%013F-HRTimelineGroup
ARMISTICE CAPITAL, LLC160,000$11.4K<0.01%-3,840,00013F-HRTimeline
Clear Street Group Inc.in group Clear Street Group Inc.149,499$10.7K<0.01%+19913F-HRTimelineGroup
Warberg Asset Management LLC69,430$4.95K<0.01%-184,37013F-HRTimeline
SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO…57,890$4.13K<0.01%new13F-HRTimelineGroup